Your browser doesn't support javascript.
loading
A RAGE-Targeted Antibody-Drug Conjugate: Surface Plasmon Resonance as a Platform for Accelerating Effective ADC Design and Development.
Healey, Gareth D; Frostell, Asa; Fagge, Tim; Gonzalez, Deyarina; Conlan, R Steven.
Affiliation
  • Healey GD; Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK. g.d.healey@swansea.ac.uk.
  • Frostell A; GE Healthcare Bio-Sciences, SE-751 84 Uppsala, Sweden. asafrostell@gmail.com.
  • Fagge T; GE Healthcare, Little Chalfont, Buckinghamshire, HP7 9NA, UK. tim.fagge@ge.com.
  • Gonzalez D; Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK. d.gonzalez@swansea.ac.uk.
  • Conlan RS; Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK. r.s.conlan@swansea.ac.uk.
Antibodies (Basel) ; 8(1)2019 Jan 07.
Article in En | MEDLINE | ID: mdl-31544813
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Antibodies (Basel) Year: 2019 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Antibodies (Basel) Year: 2019 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland